Quick Takeaways
- Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for NOVOCURE LIMITED Ordinary Shares, no par value per share (NVCR).
- Disclosed ownership: 8.6%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"Soleus Capital Master Fund, L.P. disclosed 8.6% ownership in NOVOCURE LIMITED Ordinary Shares, no par value per share (NVCR) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. | 8.6% | 9,644,872 | 0 | 9,644,872 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital, LLC | 8.6% | 9,644,872 | 0 | 9,644,872 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Group, LLC | 8.6% | 9,644,872 | 0 | 9,644,872 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Management, L.P. | 8.6% | 9,644,872 | 0 | 9,644,872 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus GP, LLC | 8.6% | 9,644,872 | 0 | 9,644,872 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Guy Levy | 8.6% | 9,644,872 | 0 | 9,644,872 | /s/ Guy Levy | Guy Levy/Individual |